MK-0431A/ONO-5435A Phase III Clinical Trial -Metformin Add-on Regimen Comparison Study in Japanese Patients with Type 2 Diabetes Mellitus
Phase 3
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- JPRN-jRCT2080221725
- Lead Sponsor
- MSD K.K. and ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 337
Inclusion Criteria
1.Type 2 Diabetes Mellitus
2.Currently being treated with diet/exercise and on stable dose of sitagliptin for >=4 weeks, on any additional oral hypoglycemic agent (AHA) in the prior 8 weeks, and HbA1c >=6.0% and =<9.0%; or, currently being treated with diet/exercise and on stable dose of sitagliptin for >=10 weeks, not on any additional oral AHA in the prior 8 weeks, and HbA1c >=6.5% and <10.0%
Exclusion Criteria
1.Type 1 diabetes mellitus, secondary diabetes mellitus, or gestational diabetes mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method